Fisker Raises $340M Via Debt, With Potential Option To Increase To $680M
Fisker Inc (NYSE:FSR) has signed a securities purchase agreement in connection with its intention to offer $340 million of 0% senior unsecured…
Why Tivic Health (TIVC) Stock Is Down Over 40%
Tivic Health Systems Inc (NASDAQ: TIVC) shares are trading lower by 46% to $0.059 Monday morning after the company priced its public offering of 32.5 million shares at
What’s Going On With Fisker Stock Today?
Fisker Inc (NYSE: FSR) shares are trading higher. The company announced a convertible notes offering Monday morning.
Fisker Announces $340M Convertible Notes Offering, Potential to Increase to $680M
Fisker Inc. (NYSE:FSR) ("Fisker"), driven by a mission to create the world's most emotional and sustainable electric vehicles, today announced the signing of a securities purchase agreement in connection
Why Curis (CRIS) Shares Are Nosediving Thursday
Curis, Inc. (NASDAQ: CRIS) shares are trading lower by 8.29% to $0.75 Thursday morning after the company announced a $15.1 million registered direct offering.
VBI Vaccines Announces Pricing Of $18M Public Offering And $3M Concurrent Registered Direct Offering
Approximately $21 million in gross proceeds from underwritten public offering and concurrent registered direct offering add to upfront payment from Brii Biosciences for a combined $33 million to be
Why Altamira Therapeutics (CYTO) Stock Is Getting Hammered
Altamira Therapeutics Ltd (NASDAQ: CYTO) shares are trading lower by 19.23% to $0.44 Thursday morning after the company announced pricing of a $5 million public offer
Why Allarity Therapeutics Stock Is Tanking Today
Allarity Therapeutics Inc (NASDAQ: ALLR) shares are diving Thursday after the company announced the pricing of a public offering.
Altamira Therapeutics Priced 11.11M Shares At $0.45/Share
Altamira Therapeutics Ltd. ("Company") (NASDAQ:CYTO), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver, announced today the pricing of a public offering
Transphorm Announces Commencement Of $15M Rights Offering
Transphorm, Inc. (NASDAQ:TGAN) ("Transphorm" or the "Company") announced today that it has commenced its previously-announced rights offering. If the rights offering is fully subscribed, the Company